Nevertheless, antibodies to Gliomedin and Contactin-1 are mostly associated with the demyelinating form of GBS, acute inflammatory demyelinating polyneuropathy (AIDP), and with CIDP (Devaux et al., 2012; Querol et al., 2012). Here, CNTN1 is linked to Guillain-Barre syndrome, familial.